Filing Details
- Accession Number:
- 0001209191-17-026571
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-04-11 16:24:11
- Reporting Period:
- 2017-04-07
- Filing Date:
- 2017-04-11
- Accepted Time:
- 2017-04-11 16:24:11
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 879169 | Incyte Corp | INCY | Services-Commercial Physical & Biological Research (8731) | 943136539 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1673776 | H Steven Stein | 1801 Augustine Cut-Off Wilmington DE 19803 | Evp & Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-04-07 | 27,000 | $88.68 | 41,648 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2017-04-07 | 5,000 | $95.76 | 46,648 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-04-07 | 27,000 | $137.88 | 19,648 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-04-07 | 5,000 | $137.91 | 14,648 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2017-04-07 | 27,000 | $0.00 | 27,000 | $88.68 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2017-04-07 | 5,000 | $0.00 | 5,000 | $95.76 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 15,891 | 2022-03-01 | No | 4 | M | Direct | |
| 13,262 | 2023-01-06 | No | 4 | M | Direct |
Footnotes
- Represents weighted average sale price. Actual sale prices ranged from $136.55 - $139.74.
- Reporting person undertakes to provide upon request by Securites and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within range indicated.
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person.
- Represents weighted average sale price. Actual sale prices ranged from $136.61 - $139.85.
- Beginning March 2, 2015, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years.
- Beginning January 7, 2016, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years
Billionaire Hedge Funds
